2cureX publishes year-end report for the fiscal year 2018
2cureX AB (“2cureX”) hereby publishes the year-end report for the fourth quarter and the fiscal year 2018. The year-end report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Ole Thastrup comments“The success of the past fiscal year has enabled us to accelerate the launch of IndiTreat® and already in the second half of 2019 we plan a pre-launch in selected markets followed by a potentially earlier market launch than was initially communicated. Recently, we presented interim results from the